SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 39,756.00 |
Book Value / Share | 19.48 |
Price / Book | n/a |
NCAV ($M) | -28,131.00 |
NCAV / Share | -13.79 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.21 |
Return on Assets (ROA) | 0.14 |
Return on Equity (ROE) | 0.29 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.71 |
Current Ratio | 0.90 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 26,447.00 |
Assets | 94,334.00 |
Liabilities | 54,578.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 46,660.00 |
Operating Income | 12,642.00 |
Net Income | 14,850.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 14,458.00 |
Cash from Investing | 5,596.00 |
Cash from Financing | -14,278.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock Inc. | 6.10 | 6.41 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
167,573 | 789,240 | 21.23 | |
198,468 | 1,158,463 | 17.13 | |
592,261 | 2,088,600 | 28.36 | |
255,964 | 1,228,556 | 20.83 | |
296,222 | 1,364,066 | 21.72 | |
(click for more detail) |
Similar Companies | |
---|---|
ABBV – AbbVie Inc. | ABT – Abbott Laboratories |
ADCT – ADC Therapeutics SA | ANRO – Alto Neuroscience, Inc. |
ANVS – Annovis Bio, Inc. |
Financial data and stock pages provided by
Fintel.io